Life Sciences

Comprehensive Approach
Data Driven Insight
We work with pharmaceutical and medical technology firms to align business, operations, research and information technology in order to transform their organization and improve portfolio performance.
Steve Sapletal
After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?
2014 was a banner year for mergers and acquisitions globally, but few sectors dominated the deal-making cycle like pharmaceuticals and biotech.

As you face regulatory shifts, profit pressures and an accelerated M&A environment, is your organization focused on thriving and growing over the next five years?

If so, then three items are likely at the top of your operations agenda: leverage analytics, drive greater efficiencies and master M&A transformations. We can assist with all three: We extract deep insights from complex data arrays using advanced approaches and tools like the Bearing Point HyperCube. We help you use these insights to structure and run your operations more intelligently, efficiently and profitably—and with greater foresight. We navigate the complexities of any M&A process by planning and executing diligence, acquisition and carve out projects complete with tools, templates and processes that give you tighter control and more predictable outcomes.

Sound like magic sauce? Perhaps, but clients tell us that our approach is comprehensive and the results are real.

Data Management
Many of today’s pharmaceutical companies have been formed by a variety of mergers, acquisitions, divestitures and joint ventures, making data management and systems integration an overwhelming burden. We can help.
Predictive Analytics
International regulators are requiring Life Science companies to identify biomarkers and related characteristics that correlate to patient outcomes. While analytics in the industry are advanced, there is strong demand for new technologies to quickly identify predictive variables from complex data sets.
Date : October 6, 2015

What are the biggest barriers to implementing E-prescribing? Jim Bedford shares his perspective. 

Date : September 29, 2015
A Concur Travel and Concur Expense solution delivers key improvements, addresses more than 100 business requirements.
By Jim Bedford and Munzoor Shaikh, West Monroe and Brian Kemper, Hospira
Date : September 14, 2015
Mergers and acquisitions are an increasingly common way for organizations to grow, expand their client base, add new products and services, and enter new geographies. Despite the growth in the number of transactions, few organizations have mastered the complexity of post-merger integration - in other words, how to realize the value that drove the transaction in the first place. In this article, we describe the “lynchpins” of integration – that is, the most critical individuals that each business function needs to provide to make the integration of the new business a success.